Davis Rea LTD. Cuts Stock Holdings in UnitedHealth Group Incorporated $UNH

Davis Rea LTD. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,188 shares of the healthcare conglomerate’s stock after selling 3,360 shares during the period. UnitedHealth Group makes up approximately 1.6% of Davis Rea LTD.’s portfolio, making the stock its 22nd biggest holding. Davis Rea LTD.’s holdings in UnitedHealth Group were worth $6,298,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the business. Zullo Investment Group Inc. raised its stake in shares of UnitedHealth Group by 18.4% in the 2nd quarter. Zullo Investment Group Inc. now owns 3,984 shares of the healthcare conglomerate’s stock valued at $1,243,000 after acquiring an additional 620 shares during the period. JFS Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 25.8% in the 2nd quarter. JFS Wealth Advisors LLC now owns 960 shares of the healthcare conglomerate’s stock valued at $299,000 after acquiring an additional 197 shares during the period. Blue Zone Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 89.1% in the 2nd quarter. Blue Zone Wealth Advisors LLC now owns 24,739 shares of the healthcare conglomerate’s stock valued at $7,718,000 after acquiring an additional 11,657 shares during the period. Strong Tower Advisory Services grew its holdings in UnitedHealth Group by 2.8% during the 2nd quarter. Strong Tower Advisory Services now owns 21,778 shares of the healthcare conglomerate’s stock valued at $6,794,000 after purchasing an additional 592 shares in the last quarter. Finally, Brucke Financial Inc. grew its holdings in UnitedHealth Group by 13.2% during the 2nd quarter. Brucke Financial Inc. now owns 1,280 shares of the healthcare conglomerate’s stock valued at $399,000 after purchasing an additional 149 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on UNH shares. Sanford C. Bernstein raised their price target on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a report on Wednesday. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a report on Wednesday. UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Royal Bank Of Canada decreased their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Hold” and an average price target of $383.09.

UnitedHealth Group Trading Down 3.6%

NYSE UNH opened at $354.30 on Friday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a 50-day simple moving average of $318.21 and a 200-day simple moving average of $350.41. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market capitalization of $320.88 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 2.38 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the firm posted $6.80 earnings per share. The company’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.